← Back to Search

Exercise--Rock Steady Boxing class for Parkinson's Disease (FIGHTPD Trial)

N/A
Recruiting
Led By Daniel Claassen, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant agreeable to an overnight dopaminergic medication washout period
Participant is willing and able to participate in a Rock Steady Boxing class
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

FIGHTPD Trial Summary

This trial is designed to measure the change in patients diagnosed with Parkinson's disease before, during and after a 12 week exercise program, with a focus on the glymphatic system.

Eligible Conditions
  • Parkinson's Disease
  • Glymphatic System

FIGHTPD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FIGHTPD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6 Minute Walk Test
Brief Estimate of Seconds (BEST)
Change in Beta-Amyloid Levels
+11 more
Secondary outcome measures
ActiGraphy
Neurametrix

FIGHTPD Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise--Rock Steady Boxing classExperimental Treatment1 Intervention
Participants will be going twice a week to a Rock Steady Boxing class for an hour/class. Participants will be going to this class for a total of three months.

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
856 Previous Clinical Trials
225,563 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
850 Previous Clinical Trials
669,095 Total Patients Enrolled
Daniel Claassen, MDPrincipal Investigator - Associate Professor
Vanderbilt University Hospital
Medical College Of Georgia School Of Medicine (Medical School)
Mayo Grad School Med/Mayo Fndn (Residency)
2 Previous Clinical Trials
115 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the population size of this research endeavor?

"Affirmative, the data on clinicaltrials.gov shows that this research is recruiting patients at present. This experiment was first made public on November 22nd 2019 and its most recent update occurred April 14th 2022. A total of 32 participants need to be recruited from one site for the study's completion."

Answered by AI

What are the criteria for enrollment into this research project?

"This clinical trial is accepting 32 individuals afflicted with glial cells aged 55 to 80. Applicants ought to meet the following prerequisites: a diagnosis of Parkinson's disease that meets UK Brain Bank Criteria, responsiveness to levodopa or similar medication, readiness and capacity to join Rock Steady Boxing classes, no consistent aerobic or non-aerobic exercise in previous 6 months, agreeable submission for overnight dopaminergic drug washout period as well as having proper means of attending study visits and boxing sessions."

Answered by AI

Is there an age cutoff for enrollment in the trial?

"The minimum age for consideration in this trial is 55 and the maximum is 80. Conversely, there are 30 studies that accept enrollees who are younger than 18 years old and 496 trials which involve adults over 65."

Answered by AI

Are there any open enrollment periods for this clinical experiment?

"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is still recruiting participants since its inception in November 2019 and most recent update in April 2022. The study requires 32 patients from a single site."

Answered by AI
~6 spots leftby Mar 2025